community download

Download Roman Ivanov's presentation

Considerations in building a pipeline of mAb biosimilars for emerging markets

Bringing a drug to market is a complicated process. Bringing a drug to an emerging market requirs a different set of considerations.

Download this presentation by Roman Ivanov to find out more:

  • Characteristics of emerging markets
  • Regulatory environment for biosimilars
  • BCD-020 – rituximab biosimilar Non-clinical studies
  • BCD-020 – rituximab biosimilar Clinical studies
  • Challenges
  • Interchangeability of biologics
  • Incentives for local manufacturing
  • Success factors for emerging markets

Thank you for your interest. To receive your copy of the PDF, please fill in the form to your right.

Thanks,
World Biosimilar Congress Team
 

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (842Kb in size)